Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Acne Vulgaris Treatment Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026

  • Purchase Options

 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

The global Acne Vulgaris Treatment Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

Acne Vulgaris, commonly referred to as acne vulgaris, is a chronic skin disorder that occurs when too much oil (sebum) is produced by the sebaceous glands, blocked hair follicles, or other problems in the skin. The resulting blemish is usually visible on the surface of the skin, creating unsightly bumps. Also called common acne, one of the causes of this condition is hormonal, particularly around puberty. The appearance of acne vulgaris varies from individual to individual but is usually associated with a large amount of oil production in the body, which may be caused by the excess production of testosterone.

The growing prevalence of acne is a prime factor driving market growth of the acne vulgaris treatment. According to the American Academy of Dermatology Association, acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. Around 85 percent of people between the ages of 12 and 24 experience at least minor acne. Moreover, the advent of new and advanced acne treatment coupled with the penetration of the generics in the acne treatment will further favor the market growth of the acne vulgaris treatment.

North America is expected to gain significant growth over the forecast period and this is attributed to the high prevalence of skin disorder coupled with the increasing healthcare expenditure in the region. According to the U.S. Centers for Medicare & Medicaid Services, the U.S. health care spending grew 4.6 percent in 2018, reaching $3.6 trillion or US$11,172 per person.  As a share of the nation's Gross Domestic Product, health spending accounted for 17.7 percent

Key Developments:

  1. In September 2020, Alembic Pharmaceuticals announces the launch of their bioequivalent and therapeutically equivalent product to Differin Gel 0.3% (Galderma), Adapalene Gel USP 0.3%, a topical retinoid for the treatment of acne vulgaris in patients 12 years and older.
  2. In December 2019, Bausch Health Companies Inc. and its dermatology business, Ortho Dermatologics, announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for ARAZLOTM (tazarotene) Lotion, 0.045%, for the topical treatment of acne vulgaris in patients nine years of age and older.
  3. In February 2020, Sun Pharmaceutical Industries announced that it has launched Absorica LD capsules used for the management of severe nodular acne in the US market. Absorica LD offers the proven efficacy and safety of Absorica at a lower dose.
  4. In August 2020, Cassiopea SpA announced that the United States Food and Drug Administration (FDA) approved Winlevi® (clascoterone cream 1%) for the treatment of acne in patients 12 years and older.

The Acne Vulgaris Treatment Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Acne Vulgaris Treatment Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Common Pharma Inc
  • Cutanea Life Sciences Inc
  • Dermira Inc
  • ELORAC Inc
  • Ensol Biosciences Inc
  • Foamix Pharmaceuticals Ltd
  • Galderma SA
  • GlaxoSmithKline Plc
  • Helix BioMedix Inc
  • Hovione FarmaCiencia SA
  • Lee's Pharmaceutical Holdings Ltd
  • LEO Pharma A/S
  • Novabiotics Ltd
  • Novan Inc
  • Novartis AG
  • Paratek Pharmaceuticals Inc
  • Pfizer Inc
  • Phosphagenics Ltd

By the Product Type, the market is primarily segmented into:

  • CB-0601
  • CJM-112
  • CLS-007
  • Dapsone
  • DFD-10
  • DLX-2323
  • Others

By Applications, the market is segmented into:

  • Clinic
  • Hospital
  • Others

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Acne Vulgaris Treatment Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Acne Vulgaris Treatment Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Acne Vulgaris Treatment Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Acne Vulgaris Treatment Market

The Acne Vulgaris Treatment Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Acne Vulgaris Treatment Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

Executive Summary
1 Industry Overview of Acne Vulgaris Treatment
1.1 Definition of Acne Vulgaris Treatment
1.2 Acne Vulgaris Treatment Segment by Type
1.2.1 Global Acne Vulgaris Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 CB-0601
1.2.3 CJM-112
1.2.4 CLS-007
1.2.5 Dapsone
1.2.6 DFD-10
1.2.7 DLX-2323
1.2.8 Others
1.3 Acne Vulgaris Treatment Segment by Applications
1.3.1 Global Acne Vulgaris Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Acne Vulgaris Treatment Overall Market
1.4.1 Global Acne Vulgaris Treatment Revenue (2014-2025)
1.4.2 Global Acne Vulgaris Treatment Production (2014-2025)
1.4.3 North America Acne Vulgaris Treatment Status and Prospect (2014-2025)
1.4.4 Europe Acne Vulgaris Treatment Status and Prospect (2014-2025)
1.4.5 China Acne Vulgaris Treatment Status and Prospect (2014-2025)
1.4.6 Japan Acne Vulgaris Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Acne Vulgaris Treatment Status and Prospect (2014-2025)
1.4.8 India Acne Vulgaris Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Acne Vulgaris Treatment
2.3 Manufacturing Process Analysis of Acne Vulgaris Treatment
2.4 Industry Chain Structure of Acne Vulgaris Treatment

3 Development and Manufacturing Plants Analysis of Acne Vulgaris Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Acne Vulgaris Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Acne Vulgaris Treatment
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Acne Vulgaris Treatment Production and Capacity Analysis
4.2 Acne Vulgaris Treatment Revenue Analysis
4.3 Acne Vulgaris Treatment Price Analysis
4.4 Market Concentration Degree

5 Acne Vulgaris Treatment Regional Market Analysis
5.1 Acne Vulgaris Treatment Production by Regions
5.1.1 Global Acne Vulgaris Treatment Production by Regions
5.1.2 Global Acne Vulgaris Treatment Revenue by Regions
5.2 Acne Vulgaris Treatment Consumption by Regions
5.3 North America Acne Vulgaris Treatment Market Analysis
5.3.1 North America Acne Vulgaris Treatment Production
5.3.2 North America Acne Vulgaris Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Acne Vulgaris Treatment Import and Export
5.4 Europe Acne Vulgaris Treatment Market Analysis
5.4.1 Europe Acne Vulgaris Treatment Production
5.4.2 Europe Acne Vulgaris Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Acne Vulgaris Treatment Import and Export
5.5 China Acne Vulgaris Treatment Market Analysis
5.5.1 China Acne Vulgaris Treatment Production
5.5.2 China Acne Vulgaris Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Acne Vulgaris Treatment Import and Export
5.6 Japan Acne Vulgaris Treatment Market Analysis
5.6.1 Japan Acne Vulgaris Treatment Production
5.6.2 Japan Acne Vulgaris Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Acne Vulgaris Treatment Import and Export
5.7 Southeast Asia Acne Vulgaris Treatment Market Analysis
5.7.1 Southeast Asia Acne Vulgaris Treatment Production
5.7.2 Southeast Asia Acne Vulgaris Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Acne Vulgaris Treatment Import and Export
5.8 India Acne Vulgaris Treatment Market Analysis
5.8.1 India Acne Vulgaris Treatment Production
5.8.2 India Acne Vulgaris Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Acne Vulgaris Treatment Import and Export

6 Acne Vulgaris Treatment Segment Market Analysis (by Type)
6.1 Global Acne Vulgaris Treatment Production by Type
6.2 Global Acne Vulgaris Treatment Revenue by Type
6.3 Acne Vulgaris Treatment Price by Type

7 Acne Vulgaris Treatment Segment Market Analysis (by Application)
7.1 Global Acne Vulgaris Treatment Consumption by Application
7.2 Global Acne Vulgaris Treatment Consumption Market Share by Application (2014-2019)

8 Acne Vulgaris Treatment Major Manufacturers Analysis
8.1 Common Pharma Inc
8.1.1 Common Pharma Inc Acne Vulgaris Treatment Production Sites and Area Served
8.1.2 Common Pharma Inc Product Introduction, Application and Specification
8.1.3 Common Pharma Inc Acne Vulgaris Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Cutanea Life Sciences Inc
8.2.1 Cutanea Life Sciences Inc Acne Vulgaris Treatment Production Sites and Area Served
8.2.2 Cutanea Life Sciences Inc Product Introduction, Application and Specification
8.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Dermira Inc
8.3.1 Dermira Inc Acne Vulgaris Treatment Production Sites and Area Served
8.3.2 Dermira Inc Product Introduction, Application and Specification
8.3.3 Dermira Inc Acne Vulgaris Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 ELORAC Inc
8.4.1 ELORAC Inc Acne Vulgaris Treatment Production Sites and Area Served
8.4.2 ELORAC Inc Product Introduction, Application and Specification
8.4.3 ELORAC Inc Acne Vulgaris Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Ensol Biosciences Inc
8.5.1 Ensol Biosciences Inc Acne Vulgaris Treatment Production Sites and Area Served
8.5.2 Ensol Biosciences Inc Product Introduction, Application and Specification
8.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Foamix Pharmaceuticals Ltd
8.6.1 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Production Sites and Area Served
8.6.2 Foamix Pharmaceuticals Ltd Product Introduction, Application and Specification
8.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Galderma SA
8.7.1 Galderma SA Acne Vulgaris Treatment Production Sites and Area Served
8.7.2 Galderma SA Product Introduction, Application and Specification
8.7.3 Galderma SA Acne Vulgaris Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 GlaxoSmithKline Plc
8.8.1 GlaxoSmithKline Plc Acne Vulgaris Treatment Production Sites and Area Served
8.8.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
8.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Helix BioMedix Inc
8.9.1 Helix BioMedix Inc Acne Vulgaris Treatment Production Sites and Area Served
8.9.2 Helix BioMedix Inc Product Introduction, Application and Specification
8.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Hovione FarmaCiencia SA
8.10.1 Hovione FarmaCiencia SA Acne Vulgaris Treatment Production Sites and Area Served
8.10.2 Hovione FarmaCiencia SA Product Introduction, Application and Specification
8.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Lee's Pharmaceutical Holdings Ltd
8.12 LEO Pharma A/S
8.13 Novabiotics Ltd
8.14 Novan Inc
8.15 Novartis AG
8.16 Paratek Pharmaceuticals Inc
8.17 Pfizer Inc
8.18 Phosphagenics Ltd

9 Development Trend of Analysis of Acne Vulgaris Treatment Market
9.1 Global Acne Vulgaris Treatment Market Trend Analysis
9.1.1 Global Acne Vulgaris Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 Acne Vulgaris Treatment Regional Market Trend
9.2.1 North America Acne Vulgaris Treatment Forecast 2019-2025
9.2.2 Europe Acne Vulgaris Treatment Forecast 2019-2025
9.2.3 China Acne Vulgaris Treatment Forecast 2019-2025
9.2.4 Japan Acne Vulgaris Treatment Forecast 2019-2025
9.2.5 Southeast Asia Acne Vulgaris Treatment Forecast 2019-2025
9.2.6 India Acne Vulgaris Treatment Forecast 2019-2025
9.3 Acne Vulgaris Treatment Market Trend (Product Type)
9.4 Acne Vulgaris Treatment Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Acne Vulgaris Treatment Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Table
List of Tables and Figures
Figure Picture of Acne Vulgaris Treatment
Table Global Acne Vulgaris Treatment Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Acne Vulgaris Treatment Production Market Share by Types in 2018
Figure CB-0601 Product Picture
Figure CJM-112 Product Picture
Figure CLS-007 Product Picture
Figure Dapsone Product Picture
Figure DFD-10 Product Picture
Figure DLX-2323 Product Picture
Figure Others Product Picture
Table Global Acne Vulgaris Treatment Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Acne Vulgaris Treatment Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global Acne Vulgaris Treatment Revenue (Million USD) (2014-2025)
Figure Global Acne Vulgaris Treatment Production (K Pcs) (2014-2025)
Figure North America Acne Vulgaris Treatment Market Size (Million USD) (2014-2025)
Figure Europe Acne Vulgaris Treatment Market Size (Million USD) (2014-2025)
Figure China Acne Vulgaris Treatment Market Size (Million USD) (2014-2025)
Figure Japan Acne Vulgaris Treatment Market Size (Million USD) (2014-2025)
Figure Southeast Asia Acne Vulgaris Treatment Market Size (Million USD) (2014-2025)
Figure India Acne Vulgaris Treatment Market Size (Million USD) (2014-2025)
Table Acne Vulgaris Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Acne Vulgaris Treatment in 2018
Figure Manufacturing Process Analysis of Acne Vulgaris Treatment
Figure Industry Chain Structure of Acne Vulgaris Treatment
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Acne Vulgaris Treatment Manufacturing Plants Distribution
Table Acne Vulgaris Treatment Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Acne Vulgaris Treatment Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Acne Vulgaris Treatment Production (K Pcs) of Major Manufacturers (2014-2019)
Table Acne Vulgaris Treatment Production Market Share of Major Manufacturers (2014-2019)
Figure Acne Vulgaris Treatment Production Share by Manufacturers in 2018
Table Acne Vulgaris Treatment Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Acne Vulgaris Treatment Revenue Market Share of Major Manufacturers (2014-2019)
Figure Acne Vulgaris Treatment Revenue Share by Manufacturers in 2018
Table Acne Vulgaris Treatment Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Acne Vulgaris Treatment Production by Regions 2014-2019 (K Pcs)
Table Global Acne Vulgaris Treatment Production Market Share by Regions 2014-2019
Figure Global Acne Vulgaris Treatment Production Market Share by Regions in 2018
Table Global Acne Vulgaris Treatment Revenue by Regions 2014-2019 (Million USD)
Table Global Acne Vulgaris Treatment Revenue Market Share by Regions 2014-2019
Figure Global Acne Vulgaris Treatment Revenue Market Share by Regions in 2018
Table Global Acne Vulgaris Treatment Consumption by Regions 2014-2019 (K Pcs)
Table Global Acne Vulgaris Treatment Consumption Market Share by Regions 2014-2019
Figure North America Acne Vulgaris Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure North America Acne Vulgaris Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table North America Acne Vulgaris Treatment Production, Consumption Import and Export (K Pcs)
Figure Europe Acne Vulgaris Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Acne Vulgaris Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Acne Vulgaris Treatment Production, Consumption Import and Export (K Pcs)
Figure China Acne Vulgaris Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure China Acne Vulgaris Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table China Acne Vulgaris Treatment Production, Consumption Import and Export (K Pcs)
Figure Japan Acne Vulgaris Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Acne Vulgaris Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Acne Vulgaris Treatment Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Acne Vulgaris Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Acne Vulgaris Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Acne Vulgaris Treatment Production, Consumption Import and Export (K Pcs)
Figure India Acne Vulgaris Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure India Acne Vulgaris Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table India Acne Vulgaris Treatment Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Acne Vulgaris Treatment Market Share by Application (2014-2019)
Figure Global Value (Consumption) Acne Vulgaris Treatment Market Share by Application (2014-2019)
Table Common Pharma Inc Acne Vulgaris Treatment Production Sites and Area Served
Table Common Pharma Inc Acne Vulgaris Treatment Product Introduction, Application and Specification
Table Common Pharma Inc Acne Vulgaris Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Common Pharma Inc Acne Vulgaris Treatment Production Growth Rate (2014-2019)
Table Common Pharma Inc Acne Vulgaris Treatment Production Market Share (2014-2019)
Figure Common Pharma Inc Acne Vulgaris Treatment Revenue Market Share (2014-2019)
Table Common Pharma Inc Acne Vulgaris Treatment Main Business and Markets Served
Table Cutanea Life Sciences Inc Acne Vulgaris Treatment Production Sites and Area Served
Table Cutanea Life Sciences Inc Acne Vulgaris Treatment Product Introduction, Application and Specification
Table Cutanea Life Sciences Inc Acne Vulgaris Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cutanea Life Sciences Inc Acne Vulgaris Treatment Production Growth Rate (2014-2019)
Table Cutanea Life Sciences Inc Acne Vulgaris Treatment Production Market Share (2014-2019)
Figure Cutanea Life Sciences Inc Acne Vulgaris Treatment Revenue Market Share (2014-2019)
Table Cutanea Life Sciences Inc Acne Vulgaris Treatment Main Business and Markets Served
Table Dermira Inc Acne Vulgaris Treatment Production Sites and Area Served
Table Dermira Inc Acne Vulgaris Treatment Product Introduction, Application and Specification
Table Dermira Inc Acne Vulgaris Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Dermira Inc Acne Vulgaris Treatment Production Growth Rate (2014-2019)
Table Dermira Inc Acne Vulgaris Treatment Production Market Share (2014-2019)
Figure Dermira Inc Acne Vulgaris Treatment Revenue Market Share (2014-2019)
Table Dermira Inc Acne Vulgaris Treatment Main Business and Markets Served
Table ELORAC Inc Acne Vulgaris Treatment Production Sites and Area Served
Table ELORAC Inc Acne Vulgaris Treatment Product Introduction, Application and Specification
Table ELORAC Inc Acne Vulgaris Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ELORAC Inc Acne Vulgaris Treatment Production Growth Rate (2014-2019)
Table ELORAC Inc Acne Vulgaris Treatment Production Market Share (2014-2019)
Figure ELORAC Inc Acne Vulgaris Treatment Revenue Market Share (2014-2019)
Table ELORAC Inc Acne Vulgaris Treatment Main Business and Markets Served
Table Ensol Biosciences Inc Acne Vulgaris Treatment Production Sites and Area Served
Table Ensol Biosciences Inc Acne Vulgaris Treatment Product Introduction, Application and Specification
Table Ensol Biosciences Inc Acne Vulgaris Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ensol Biosciences Inc Acne Vulgaris Treatment Production Growth Rate (2014-2019)
Table Ensol Biosciences Inc Acne Vulgaris Treatment Production Market Share (2014-2019)
Figure Ensol Biosciences Inc Acne Vulgaris Treatment Revenue Market Share (2014-2019)
Table Ensol Biosciences Inc Acne Vulgaris Treatment Main Business and Markets Served
Table Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Production Sites and Area Served
Table Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Product Introduction, Application and Specification
Table Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Production Growth Rate (2014-2019)
Table Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Production Market Share (2014-2019)
Figure Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Revenue Market Share (2014-2019)
Table Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Main Business and Markets Served
Table Galderma SA Acne Vulgaris Treatment Production Sites and Area Served
Table Galderma SA Acne Vulgaris Treatment Product Introduction, Application and Specification
Table Galderma SA Acne Vulgaris Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Galderma SA Acne Vulgaris Treatment Production Growth Rate (2014-2019)
Table Galderma SA Acne Vulgaris Treatment Production Market Share (2014-2019)
Figure Galderma SA Acne Vulgaris Treatment Revenue Market Share (2014-2019)
Table Galderma SA Acne Vulgaris Treatment Main Business and Markets Served
Table GlaxoSmithKline Plc Acne Vulgaris Treatment Production Sites and Area Served
Table GlaxoSmithKline Plc Acne Vulgaris Treatment Product Introduction, Application and Specification
Table GlaxoSmithKline Plc Acne Vulgaris Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Acne Vulgaris Treatment Production Growth Rate (2014-2019)
Table GlaxoSmithKline Plc Acne Vulgaris Treatment Production Market Share (2014-2019)
Figure GlaxoSmithKline Plc Acne Vulgaris Treatment Revenue Market Share (2014-2019)
Table GlaxoSmithKline Plc Acne Vulgaris Treatment Main Business and Markets Served
Table Helix BioMedix Inc Acne Vulgaris Treatment Production Sites and Area Served
Table Helix BioMedix Inc Acne Vulgaris Treatment Product Introduction, Application and Specification
Table Helix BioMedix Inc Acne Vulgaris Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Helix BioMedix Inc Acne Vulgaris Treatment Production Growth Rate (2014-2019)
Table Helix BioMedix Inc Acne Vulgaris Treatment Production Market Share (2014-2019)
Figure Helix BioMedix Inc Acne Vulgaris Treatment Revenue Market Share (2014-2019)
Table Helix BioMedix Inc Acne Vulgaris Treatment Main Business and Markets Served
Table Hovione FarmaCiencia SA Acne Vulgaris Treatment Production Sites and Area Served
Table Hovione FarmaCiencia SA Acne Vulgaris Treatment Product Introduction, Application and Specification
Table Hovione FarmaCiencia SA Acne Vulgaris Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Hovione FarmaCiencia SA Acne Vulgaris Treatment Production Growth Rate (2014-2019)
Table Hovione FarmaCiencia SA Acne Vulgaris Treatment Production Market Share (2014-2019)
Figure Hovione FarmaCiencia SA Acne Vulgaris Treatment Revenue Market Share (2014-2019)
Table Hovione FarmaCiencia SA Acne Vulgaris Treatment Main Business and Markets Served
Table Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Production Sites and Area Served
Table LEO Pharma A/S Acne Vulgaris Treatment Production Sites and Area Served
Table Novabiotics Ltd Acne Vulgaris Treatment Production Sites and Area Served
Table Novan Inc Acne Vulgaris Treatment Production Sites and Area Served
Table Novartis AG Acne Vulgaris Treatment Production Sites and Area Served
Table Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Production Sites and Area Served
Table Pfizer Inc Acne Vulgaris Treatment Production Sites and Area Served
Table Phosphagenics Ltd Acne Vulgaris Treatment Production Sites and Area Served
Figure Global Acne Vulgaris Treatment Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Acne Vulgaris Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Acne Vulgaris Treatment Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Acne Vulgaris Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Acne Vulgaris Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Acne Vulgaris Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Acne Vulgaris Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Acne Vulgaris Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Acne Vulgaris Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Acne Vulgaris Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Acne Vulgaris Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Acne Vulgaris Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Acne Vulgaris Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Acne Vulgaris Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Acne Vulgaris Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Acne Vulgaris Treatment by Type (2019-2025)
Table Global Consumption (K Pcs) of Acne Vulgaris Treatment by Application (2019-2025)
Table Acne Vulgaris Treatment Distributors List
Table Acne Vulgaris Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us